Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from TripSitter Clinic Ltd ( (TSE:KETA) ).
TripSitter Clinic has converted $373,250 of liabilities into 6,635,555 common shares priced at $0.05625, with the new shares subject to a hold period until August 3, 2026. The transaction, classified as a related-party deal due to participation by CFO Zeeshan Khan and insider Cabazon Capital Corp., was exempt from formal valuation and minority approval requirements under MI 61‑101 and was closed on an expedited basis.
Following the settlement, Cabazon Capital increased its stake from 16.94% to 19.92% of TripSitter’s outstanding common shares, while Oregon Management FZ-LLC emerged as a significant shareholder with an 18.05% position. The move strengthens TripSitter’s balance sheet while consolidating insider and strategic investor ownership, potentially increasing governance influence and signaling continued investor commitment to the company’s long-term prospects.
The most recent analyst rating on (TSE:KETA) stock is a Sell with a C$0.06 price target. To see the full list of analyst forecasts on TripSitter Clinic Ltd stock, see the TSE:KETA Stock Forecast page.
Spark’s Take on KETA Stock
According to Spark, TipRanks’ AI Analyst, KETA is a Underperform.
The score is driven primarily by very weak financial performance (near-zero revenue, ongoing losses, negative equity, and continued cash burn), which outweighs any near-term technical oversold signals. Valuation is also unattractive/unclear due to negative earnings and no dividend support.
To see Spark’s full report on KETA stock, click here.
More about TripSitter Clinic Ltd
TripSitter Clinic Ltd. is a Canadian company listed on the CSE under the ticker KETA, operating in the psychedelic-assisted therapy and mental health services space. The company focuses on providing clinical treatments and related services, positioning itself within the emerging medical psychedelics and wellness market.
Average Trading Volume: 35,479
Technical Sentiment Signal: Sell
Current Market Cap: C$532.7K
See more insights into KETA stock on TipRanks’ Stock Analysis page.